Growth Metrics

Evolent Health (EVH) Acquisitions (2016 - 2025)

Evolent Health has reported Acquisitions over the past 11 years, most recently at $1.4 million for Q4 2025.

  • For Q4 2025, Acquisitions fell 89.85% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $57.4 million, up 86.96%, while the annual FY2025 figure was $57.4 million, 86.96% up from the prior year.
  • Acquisitions for Q4 2025 was $1.4 million at Evolent Health, up from -$2000.0 in the prior quarter.
  • Over five years, Acquisitions peaked at $386.7 million in Q1 2023 and troughed at -$2000.0 in Q3 2025.
  • A 5-year average of $45.5 million and a median of $4.5 million in 2025 define the central range for Acquisitions.
  • Biggest five-year swings in Acquisitions: skyrocketed 552362.86% in 2023 and later tumbled 100.02% in 2025.
  • Year by year, Acquisitions stood at $47.1 million in 2021, then crashed by 93.44% to $3.1 million in 2022, then plummeted by 50.74% to $1.5 million in 2023, then soared by 805.26% to $13.8 million in 2024, then tumbled by 89.85% to $1.4 million in 2025.
  • Business Quant data shows Acquisitions for EVH at $1.4 million in Q4 2025, -$2000.0 in Q3 2025, and $51.5 million in Q2 2025.